Determination of atrasentan by high perf
โ
Peter D. Bryan; Lisa B. Sapochak; Michelle M. Tames; Robert J. Padley; Tawakol A
๐
Article
๐
2001
๐
John Wiley and Sons
๐
English
โ 108 KB
๐ 2 views
Atrasentan is an endothelin antagonist selective for the ET A receptor in development at Abbott Laboratories for the treatment of cardiovascular disease and cell proliferation disorders. A simple and sensitive chromatographic method for the determination of atrasentan in human plasma has been develo